Terms: = Lung cancer AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC AND Treatment
40 results:
1. Clinicopathological, metastatic and prognostic features of stage IV esophageal adenocarcinoma versus squamous cell carcinoma: a SEER database analysis.
Pan L; Zhang Y; Gao Y; Qiu J
Chin Clin Oncol; 2024 Feb; 13(1):2. PubMed ID: 38372056
[TBL] [Abstract] [Full Text] [Related]
2. Serum immune mediators as novel predictors of response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients with high tissue-PD-L1 expression.
Raza A; Mohsen R; Kanbour A; Zar Gul AR; Philip A; Vijayakumar S; Hydrose S; Prabhu KS; Al-Suwaidi AK; Inchakalody VP; Merhi M; Abo El-Ella DM; Tauro MA; Akbar S; Al-Bozom I; Abualainin W; Al-Abdulla R; Sirriya SA; Hassnad S; Uddin S; Mohamed Ibrahim MI; Al Homsi U; Demime S
Front Immunol; 2023; 14():1157100. PubMed ID: 37256148
[TBL] [Abstract] [Full Text] [Related]
3. Circulating exosomal immuno-oncological checkpoints and cytokines are potential biomarkers to monitor tumor response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients.
Akbar S; Raza A; Mohsin R; Kanbour A; Qadri S; Parray A; Zar Gul AR; Philip A; Vijayakumar S; Merhi M; Hydrose S; Inchakalody VP; Al-Abdulla R; Abualainin W; Sirriya SA; Al-Bozom I; Uddin S; Khan OM; Mohamed Ibrahim MI; Al Homsi U; Dermime S
Front Immunol; 2022; 13():1097117. PubMed ID: 36741391
[TBL] [Abstract] [Full Text] [Related]
4. Engineered APOBEC3C Sequencing Enables Bisulfite-Free and Direct Detection of DNA Methylation at a Single-Base Resolution.
Wang M; Xie NB; Chen KK; Ji TT; Xiong J; Guo X; Yu SY; Tang F; Xie C; Feng YQ; Yuan BF
Anal Chem; 2023 Jan; 95(2):1556-1565. PubMed ID: 36563112
[TBL] [Abstract] [Full Text] [Related]
5. Efficacy of liquid biopsy for disease monitoring and early prediction of tumor progression in EGFR mutation-positive non-small cell lung cancer.
Ho HL; Jiang Y; Chiang CL; Karwowska S; Yerram R; Sharma K; Scudder S; Chiu CH; Tsai CM; Palma JF; Sharma A; Chou TY
PLoS One; 2022; 17(4):e0267362. PubMed ID: 35482671
[TBL] [Abstract] [Full Text] [Related]
6. Combination atezolizumab, bevacizumab, pemetrexed and carboplatin for metastatic EGFR mutated NSCLC after TKI failure.
Lam TC; Tsang KC; Choi HC; Lee VH; Lam KO; Chiang CL; So TH; Chan WW; Nyaw SF; Lim F; Lau JO; Chik J; Kong FM; Lee AW
Lung Cancer; 2021 Sep; 159():18-26. PubMed ID: 34303276
[TBL] [Abstract] [Full Text] [Related]
7. STAT3/miR-135b/NF-κB axis confers aggressiveness and unfavorable prognosis in non-small-cell lung cancer.
Zhao J; Wang X; Mi Z; Jiang X; Sun L; Zheng B; Wang J; Meng M; Zhang L; Wang Z; Song J; Yuan Z; Wu Z
Cell Death Dis; 2021 May; 12(5):493. PubMed ID: 33990540
[TBL] [Abstract] [Full Text] [Related]
8. Anti-Metastatic Potential of a Novel Xanthone Sourced by Swertia chirata Against In Vivo and In Vitro Breast Adenocarcinoma Frameworks.
Barua A; Choudhury P; Mandal S; Panda CK; Saha P
Asian Pac J Cancer Prev; 2020 Oct; 21(10):2865-2875. PubMed ID: 33112542
[TBL] [Abstract] [Full Text] [Related]
9. Clinical characterization and risk factors associated with cytokine release syndrome induced by COVID-19 and chimeric antigen receptor T-cell therapy.
Hong R; Zhao H; Wang Y; Chen Y; Cai H; Hu Y; Wei G; Huang H
Bone Marrow Transplant; 2021 Mar; 56(3):570-580. PubMed ID: 32943758
[TBL] [Abstract] [Full Text] [Related]
10. Reduced expression of cyld promotes cell survival and inflammation in gefitinib-treated NSCLC PC-9 cells: Targeting cyld may be beneficial for acquired resistance to gefitinib therapy.
Yuan Y; Liu L; Wang Y; Liu S
Cell Biol Int; 2020 Sep; 44(9):1911-1918. PubMed ID: 32441799
[TBL] [Abstract] [Full Text] [Related]
11. Clinical characteristics and treatment outcome of adenoid cystic carcinoma in the external auditory canal.
Chen SL; Huang SF; Ho VW; Chuang WY; Chan KC
Biomed J; 2020 Apr; 43(2):189-194. PubMed ID: 32389593
[TBL] [Abstract] [Full Text] [Related]
12. Oral administration of 3,3'-diselenodipropionic acid prevents thoracic radiation induced pneumonitis in mice by suppressing NF-kB/IL-17/G-CSF/neutrophil axis.
Gandhi KA; Goda JS; Gandhi VV; Sadanpurwala A; Jain VK; Joshi K; Epari S; Rane S; Mohanty B; Chaudhari P; Kembhavi S; Kunwar A; Gota V; Priyadarsini KI
Free Radic Biol Med; 2019 Dec; 145():8-19. PubMed ID: 31521664
[TBL] [Abstract] [Full Text] [Related]
13. Correlation of extent of ALK FISH positivity and crizotinib efficacy in three prospective studies of ALK-positive patients with non-small-cell lung cancer.
Soria JC; Ho SN; Varella-Garcia M; Iafrate AJ; Solomon BJ; Shaw AT; Blackhall F; Mok TS; Wu YL; Pestova K; Wilner KD; Polli A; Paolini J; Lanzalone S; Green S; Camidge DR
Ann Oncol; 2018 Sep; 29(9):1964-1971. PubMed ID: 30010763
[TBL] [Abstract] [Full Text] [Related]
14. Targeting EGFR in lung cancer: Current Standards and Developments.
Díaz-Serrano A; Gella P; Jiménez E; Zugazagoitia J; Paz-Ares Rodríguez L
Drugs; 2018 Jun; 78(9):893-911. PubMed ID: 29915896
[TBL] [Abstract] [Full Text] [Related]
15. The tumor antagonistic steroidal alkaloid Solanidine prompts the intrinsic suicidal signal mediated DFF-40 nuclear import and nucleosomal disruption.
Malojirao VH; Vigneshwaran V; Thirusangu P; Mahmood R; Prabhakar BT
Life Sci; 2018 Apr; 199():139-150. PubMed ID: 29524520
[TBL] [Abstract] [Full Text] [Related]
16. Expression, regulation and targeting of receptor tyrosine kinases in esophageal squamous cell carcinoma.
Kashyap MK; Abdel-Rahman O
Mol Cancer; 2018 Feb; 17(1):54. PubMed ID: 29455652
[TBL] [Abstract] [Full Text] [Related]
17. miR‑197‑3p‑induced downregulation of lysine 63 deubiquitinase promotes cell proliferation and inhibits cell apoptosis in lung adenocarcinoma cell lines.
Chen Y; Yang C
Mol Med Rep; 2018 Mar; 17(3):3921-3927. PubMed ID: 29286108
[TBL] [Abstract] [Full Text] [Related]
18. Necroptotic signaling is primed in Mycobacterium tuberculosis-infected macrophages, but its pathophysiological consequence in disease is restricted.
Stutz MD; Ojaimi S; Allison C; Preston S; Arandjelovic P; Hildebrand JM; Sandow JJ; Webb AI; Silke J; Alexander WS; Pellegrini M
Cell Death Differ; 2018 May; 25(5):951-965. PubMed ID: 29229989
[TBL] [Abstract] [Full Text] [Related]
19. A prediction model for early death in non-small cell lung cancer patients following curative-intent chemoradiotherapy.
Jochems A; El-Naqa I; Kessler M; Mayo CS; Jolly S; Matuszak M; Faivre-Finn C; Price G; Holloway L; Vinod S; Field M; Barakat MS; Thwaites D; de Ruysscher D; Dekker A; Lambin P
Acta Oncol; 2018 Feb; 57(2):226-230. PubMed ID: 29034756
[TBL] [Abstract] [Full Text] [Related]
20. 4-aryl/heteroaryl-4H-fused Pyrans as Anti-proliferative Agents: Design, Synthesis and Biological Evaluation.
Kumar D; Singh G; Sharma P; Qayum A; Mahajan G; Mintoo MJ; Singh SK; Mondhe DM; Bedi PMS; Jain SK; Gupta GK
Anticancer Agents Med Chem; 2018; 18(1):57-73. PubMed ID: 28925877
[TBL] [Abstract] [Full Text] [Related]
[Next]
